Abstract     Description     Claims  

WO020704865A   [0014]  [0014] 
WO0236734A   [0015]  [0015] 
WO0255079A   [0016] 
WO02055079A   [0016] 
US3472859A   [0019]  [0019] 
JP48026772A   [0020]  [0020] 
JP2002534416A   [0022]  [0022] 
WO0040561A   [0022] 
US6248739B   [0022] 
EP1140850A   [0022] 
JP2002534417A   [0023]  [0023] 
WO0040563A   [0023] 
US6248736B   [0023] 
EP1140851A   [0023] 
WO0198275A   [0024]  [0024] 
US2001103220A   [0024] 
JP4360872A   [0025]  [0025] 
US5985894A   [0025] 
EP498721B1   [0025] 
JP2002336843A   [0612] 
JP2003065807A   [0612] 
JP2003139616A   [0612] 

Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adlescent   [0009] 
Memoirs Department of Engineering   [0020] 
Memoirs Kyushu Inst. Tech. (Eng.)   [0020] 
Journal of Medicinal Chemistry   [0021] 
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents   [0119] 
J. Virol.   [0342]